Patents by Inventor Nahed ALSABTI

Nahed ALSABTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of methicillin resistant (MRSA)
    Patent number: 11053533
    Abstract: The invention provides a method for identifying methicillin resistant Staphylococcus aureus (MRSA) in a bacterial sample comprising the steps: classifying bacteria in the sample as Staphylococcus aureus (SA) and determining the presence or absence of the phenol soluble modulin peptide or a variant thereof wherein the presence of the PSM-mec peptide or variant thereof indicates methicillin resistant Staphylococcus aureus. The variant is preferably the formylated version of the PSM-mec peptide having a mass to charge ratio of 2415 in a singly protonated state.
    Type: Grant
    Filed: December 18, 2014
    Date of Patent: July 6, 2021
    Inventors: Gabriele Bierbaum, Christiane Szekat, Nahed Alsabti, Michaele Josten, Marion Reif
  • IDENTIFICATION OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
    Publication number: 20160355865
    Abstract: The invention provides a method for identifying methicillin resistant Staphylococcus aureus (MRSA) in a bacterial sample comprising the steps: classifying bacteria in the sample as Staphylococcus aureus (SA) and determining the presence or absence of the phenol soluble modulin peptide or a variant thereof wherein the presence of the PSM-mec peptide or variant thereof indicates methicillin resistant Staphylococcus aureus. The variant is preferably the formylated version of the PSM-mec peptide having a mass to charge ratio of 2415 in a singly protonated state.
    Type: Application
    Filed: December 18, 2014
    Publication date: December 8, 2016
    Inventors: Gabriele BIERBAUM, Christiane SZEKAT, Nahed ALSABTI, Michaele JOSTEN, Marion REIF